{Reference Type}: Journal Article
{Title}: Skeletal muscle mass and quality in gout patients versus non-gout controls: A computed tomography imaging study.
{Author}: Covello A;Toprover M;Oh C;Leroy G;Kumar A;LaMoreaux B;Mechlin M;Fields TR;Pillinger MH;Becce F;
{Journal}: Joint Bone Spine
{Volume}: 91
{Issue}: 5
{Year}: 2024 May 23
{Factor}: 5.263
{DOI}: 10.1016/j.jbspin.2024.105743
{Abstract}: <B>OBJECTIVE: </B>Patients with gout are at elevated risk of multiple vascular and metabolic comorbidities. Whether they are also at risk of sarcopenia, which is known to affect patients with other rheumatic diseases, has not been previously assessed. We examined whether patients with gout have decreased lumbar muscle quality and quantity, indicating an association between gout and sarcopenia.<BR><B>METHODS: </B>Fifty gout subjects and 25 controls, ages 45-80, underwent computed tomography imaging of the lumbosacral spine. We measured muscle quantity (skeletal muscle area [SMA] and index [SMI]) and quality (skeletal muscle radiation attenuation [SMRA] and intermuscular adipose tissue [IMAT] area and index [IMATI]) of the psoas and erector spinae muscles at the L3 level.<BR><B>RESULTS: </B>Seventy subjects (45 gout and 25 controls) were included in the analysis. Gout subjects had higher BMI, more kidney disease and hypertension, lower exercise frequency, and higher mean serum urate and creatinine vs. controls. Lumbar SMRA was significantly lower in gout subjects vs. controls, indicating reduced muscle quality. Lumbar IMAT area was significantly higher in gout subjects vs. controls, as was lumbar IMATI, indicating increased muscle adiposity. These differences persisted after adjusting for potential confounders. In contrast, there was no significant difference between gout and control groups in lumbar SMA or lumbar SMI, suggesting that muscle quantity may not be routinely affected by the diagnosis of gout.<BR><B>CONCLUSIONS: </B>Gout patients exhibit decreased lumbar muscle quality compared with controls, consistent with an association between gout and sarcopenia.